LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
32 funds hold it · Insiders net selling
Net selling: insiders sold $4.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 29, 2026
Financial period
Third Quarter 2026
Earnings per share
$0.67 expected
Revenue
Company release
Fiscal Year 2026 guidance
$5.20B to $5.25B
No comparable estimate
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 29, 2026 | $0.73est. $0.67 | +8.31%beat | $1.34BCompany release | +11.1%from $1.21B |
| Jun 30, 2026Reported Jul 30, 2026 | $0.70est. $0.61 | +15.11%beat | $1.31BSEC filing | +13.1%from $1.16B |
| Mar 31, 2026Reported Apr 30, 2026 | $0.56est. $0.47 | +18.99%beat | $1.19BSEC filing | +15.0%from $1.04B |
| Dec 31, 2025Reported Feb 12, 2026 | $0.68est. $0.65 | +4.50%beat | $1.26BAlpha Vantage | +13.1%from $1.11B |
| Sep 30, 2025Reported Oct 30, 2025 | $0.61est. $0.57 | +7.02%beat | $1.21BSEC filing | +21.6%from $994.2M |
| Jun 30, 2025Reported Jul 30, 2025 | $0.48est. $0.44 | +9.09%beat | $1.16BSEC filing | +15.2%from $1.00B |
| Mar 31, 2025Reported May 1, 2025 | $0.32est. $0.33 | -3.03%miss | $1.04BSEC filing | +12.5%from $921.0M |
| Dec 31, 2024Reported Feb 13, 2025 | $0.45est. $0.50 | -10.00%miss | $1.11BAlpha Vantage | +7.6%from $1.03B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.26B | $1.19B | $1.31B | $1.34B |
| Cost of what it sold | $466.9M | $441.6M | $478.4M | $480.1M |
| Gross profit | $792.7M | $750.3M | $830.0M | $864.4M |
| What it spent | ||||
| Research and development | $148.2M | $145.3M | $153.0M | $161.6M |
| Sales and admin | $321.5M | $349.7M | $358.7M | $375.6M |
| Total operating expenses | $469.7M | $495.0M | $511.7M | $537.2M |
| What was left | ||||
| Operating profit | $323.0M | $255.3M | $318.3M | $327.2M |
| Interest on debt | $4.2M | $3.1M | $3.0M | $3.1M |
| Profit before tax | $340.7M | $269.5M | $317.5M | $334.7M |
| Tax | $73.4M | $70.0M | $68.4M | $59.6M |
| Net profit | $267.3M | $199.5M | $249.1M | $275.1M |
| EBITDA | $410.1M | $339.7M | $388.7M | $412.3M |
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Spectral AI Q3FY26 Results: Sales miss estimate, EPS beats consensus
Leans bullishNov 11Tax withholding, not a sale: Dexcom (DXCM) EVP Brown has 1,451 shares withheld at $79.41 each.
NeutralNov 10Tax withholding, not a sale: Dexcom (DXCM) retains 1,451 shares from its chief people officer.
NeutralNov 10Not a sale: Dexcom (DXCM) withholds 1,451 shares from CEO Jacob Steven Leach for taxes.
NeutralNov 10The 1,451 shares withheld from Dexcom (DXCM)'s CFO for taxes were not sold.
NeutralNov 10Senseonics Holdings Q3 revenue up 140% to USD 19.6M
NeutralNov 10Senseonics Q3 Results: Sales jump 141.6% to $19.6M, loss narrows
NeutralNov 10Advancing type 1 diabetes care during pregnancy: a Canadian first
BullishNov 934 macro signals shaping DXCM right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
